76 related articles for article (PubMed ID: 28284201)
1. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.
Manolakis AC; Christodoulidis G; Kapsoritakis AN; Georgoulias P; Tiaka EK; Oikonomou K; Valotassiou VJ; Potamianos SP
World J Gastroenterol; 2017 Jan; 23(3):437-446. PubMed ID: 28210079
[TBL] [Abstract][Full Text] [Related]
2. Serum Serotonin Differentiates Between Disease Activity States in Crohn's Patients.
Manzella CR; Jayawardena D; Pagani W; Li Y; Alrefai WA; Bauer J; Jung B; Weber CR; Gill RK
Inflamm Bowel Dis; 2020 Sep; 26(10):1607-1618. PubMed ID: 32844174
[TBL] [Abstract][Full Text] [Related]
3. Serum laminin and collagen IV in inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Dimoulios P; Vardas E; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
J Clin Pathol; 2003 Nov; 56(11):817-20. PubMed ID: 14600124
[TBL] [Abstract][Full Text] [Related]
4. The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study.
Cantoro L; Di Sabatino A; Papi C; Margagnoni G; Ardizzone S; Giuffrida P; Giannarelli D; Massari A; Monterubbianesi R; Lenti MV; Corazza GR; Kohn A
J Crohns Colitis; 2017 Aug; 11(8):975-980. PubMed ID: 28333328
[TBL] [Abstract][Full Text] [Related]
5. The effects of apoptosis inhibitor of macrophage in kidney diseases.
Cao Y; Hu B; Fan Y; Wang W; Chi M; Nasser MI; Ma K; Liu C
Eur J Med Res; 2024 Jan; 29(1):21. PubMed ID: 38178221
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy associated with Crohn's disease.
Tamura H
World J Methodol; 2023 Jun; 13(3):67-78. PubMed ID: 37456980
[TBL] [Abstract][Full Text] [Related]
7. The comprehensive role of apoptosis inhibitor of macrophage (AIM) in pathological conditions.
Yang H; Luo Y; Lai X
Clin Exp Immunol; 2023 Jun; 212(3):184-198. PubMed ID: 36427004
[TBL] [Abstract][Full Text] [Related]
8. Role of apoptosis inhibitor of macrophages in patients with IgG4‑related disease/autoimmune pancreatitis and the clinical characteristics associated with this condition.
Tanoue S; Kanmura S; Hinokuchi M; Arima S; Sasaki F; Hashimoto S; Ido A
Biomed Rep; 2022 Oct; 17(4):82. PubMed ID: 36158321
[TBL] [Abstract][Full Text] [Related]
9. Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells.
Matsuda Y; Watanabe T; Li XK
Front Immunol; 2021; 12():682334. PubMed ID: 34276669
[TBL] [Abstract][Full Text] [Related]
10. Serum beta 2-microglobulin as a biomarker in inflammatory bowel disease.
Yılmaz B; Köklü S; Yüksel O; Arslan S
World J Gastroenterol; 2014 Aug; 20(31):10916-20. PubMed ID: 25152594
[TBL] [Abstract][Full Text] [Related]
11. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Behçet and Crohn's disease: two sides of the same coin.
Valenti S; Gallizzi R; De Vivo D; Romano C
Pediatr Rheumatol Online J; 2017 Apr; 15(1):33. PubMed ID: 28427473
[TBL] [Abstract][Full Text] [Related]
13. The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
Ono Y; Kanmura S; Morinaga Y; Oda K; Kawabata K; Arima S; Sasaki F; Nasu Y; Tanoue S; Hashimoto S; Taguchi H; Uto H; Tsubouchi H; Ido A
BMC Gastroenterol; 2017 Mar; 17(1):40. PubMed ID: 28284201
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of the clinical utility of serological biomarkers in Chinese patients with inflammatory bowel disease: 2-year clinical experience.
Zhang S; Luo J; Li J; Wu Z; Hu C; Li P; Deng C; Zhang F; Qian J; Li Y
Clin Chem Lab Med; 2017 May; 55(6):865-875. PubMed ID: 27831916
[TBL] [Abstract][Full Text] [Related]
15. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
